RAPT Therapeutics (RAPT) Shares Issued (2020 - 2024)
Historic Shares Issued for Therapeutics (RAPT) over the last 5 years, with Q4 2024 value amounting to $142.3 million.
- Therapeutics' Shares Issued rose 3096593.89% to $142.3 million in Q4 2024 from the same period last year, while for Dec 2024 it was $143.0 million, marking a year-over-year increase of 978597.1%. This contributed to the annual value of $143.0 million for FY2024, which is 978597.1% up from last year.
- Latest data reveals that Therapeutics reported Shares Issued of $142.3 million as of Q4 2024, which was up 3096593.89% from $701000.0 recorded in Q2 2024.
- In the past 5 years, Therapeutics' Shares Issued ranged from a high of $142.3 million in Q4 2024 and a low of -$132.6 million during Q4 2021
- Over the past 5 years, Therapeutics' median Shares Issued value was $126500.0 (recorded in 2021), while the average stood at $8.3 million.
- In the last 5 years, Therapeutics' Shares Issued crashed by 1111911.89% in 2021 and then skyrocketed by 3096593.89% in 2024.
- Therapeutics' Shares Issued (Quarter) stood at $1.2 million in 2020, then crashed by 11119.12% to -$132.6 million in 2021, then skyrocketed by 63.49% to -$48.4 million in 2022, then skyrocketed by 100.95% to $458000.0 in 2023, then soared by 30965.94% to $142.3 million in 2024.
- Its Shares Issued was $142.3 million in Q4 2024, compared to $701000.0 in Q2 2024 and $67000.0 in Q1 2024.